For the second year in a row, Chambers USA has recognized Sharon K. Robertson, a Partner in Cohen Milstein's Antitrust practice as a "Top Ranked" individual attorney in the area of Antitrust: Plaintiff (2020, 2021).
Ms. Robertson leads Cohen Milstein’s efforts in “pay-for-delay” pharmaceutical antitrust multidistrict litigation and has been repeatedly recognized for her success in this unique area of law. Chambers has ranked Ms. Robertson “Band 2 in Antitrust: Plaintiff – New York and USA – Nationwide” (2020, 2021) and Lawdragon has included her in its “500 Leading Lawyers in America” list. In 2019, Law360 named Ms. Robertson a “Life Sciences-MVP” for her “hard-earned successes” and “record-breaking deals” and The National Law Journal named her one of nine “Elite Women of the Plaintiffs Bar,” an award that recognizes female lawyers who “have consistently excelled in high-stakes matters on behalf of plaintiffs over the course of their careers.” In 2018, the American Antitrust Institute, one of the nation’s foremost economic and competition think tanks, honored her with its prestigious “Outstanding Antitrust Litigation Achievement by a Young Lawyer” award for her role in securing a $104.75 million settlement – one of the largest recoveries on record for end-payors in In re Lidoderm Antitrust Litigation (N.D. Cal.). In 2020 Ms. Robertson helped secure a $63.5 million settlement on behalf of end-payor clients in In re Loestrin 24 FE Antitrust Litigation (D.R.I.), another record-breaking end-payor settlement.
Chambers USA 2021
- Antitrust: Mainly Plaintiff – New York – Band 1
- Antitrust: Plaintiff - USA – Nationwide – Band 2
Sharon Robertson regularly represents plaintiffs active in the pharmaceutical industry in significant antitrust proceedings.
Ms. Robertson is also recommended for her expertise in representing plaintiffs in a wide range of disputes. She is particularly expert at taking allegations of price-fixing to trial.
"She is very smart and a very good litigator." "She is a top-notch antitrust litigator."